Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
171 participants
OBSERVATIONAL
2011-05-29
2014-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Selective Fetal Growth Restriction in Monochorionic Twins - an International Investigation
NCT05952583
The National Standard for Normal Fetal Growth
NCT00912132
Fetal Growth Evaluation by Three-Dimensional Ultrasound
NCT00340171
Early Pregnancy Evaluation by Three-Dimensional Ultrasound
NCT00342290
Fetal 3D Study (Fetal Body Composition and Volumes Study)
NCT03266198
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition to 2-D ultrasound measures for analyzing fetal growth, this study recorded maternal anthropometrics and a brief interview to capture changes in health status, stress and depression, and physical activity at each follow-up visit. Four blood draws at baseline and at targeted gestational ages for the eventual identification of biomarkers indicative of fetal growth were collected. After delivery, neonatal anthropometric measures were assessed for each twin, placental biospecimens were collected, and select information about the obstetrical course and newborn status were abstracted from medical charts. These exposures and outcomes provide opportunities to further compare singleton and twin gestations with respect to maternal biomarkers of fetal growth, well-being and maternal nutritional status using banked biospecimens to determine if the biomarkers ranges established for singletons are applicable to twin gestations.
Biospecimen Description:
* Maternal blood sample (serum, plasma, white blood cells, red blood cells and PAXgene RNA) at enrollment, 1st, 3rd, 5th follow-up visits, and delivery
* Cord blood and placentas for consenting women collected at delivery
* Placenta sample or buccal swab (determining zygosity by DNA probe for same sex pairs), collected at delivery
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
NICHD Fetal Growth Study - Twin Gestations
Women with dichorionic twin gestations were enrolled between 8w0d and 13w6d and followed up to nine months (2012-2013) in this prospective cohort study.
Intervention: No intervention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 8+0 13+6 weeks of gestation
* Maternal age 18 - 45 years
* Spontaneous pregnancy or pregnancy from ovulation induction or in-vitro fertilization with known date of transfer
* Pregnancy from egg donor or embryo donor (record if anonymous or known source)
* LMP-date and crown-rump length measurement match within certain number of days according to a standard scheme (for larger twin)
* Expect to deliver at one of the participating hospitals
Exclusion Criteria
* Congenital anomalies (structural or chromosomal)
* Either twin with an increased nuchal translucency (\>99th percentile for crown-rump length; i.e. 3.5 mm or more)
* Monochorionic twins
* Crown-rump length discordancy \>10% in dichorionic twin pregnancies
18 Years
45 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Germaine M Louis, M.D.
Role: PRINCIPAL_INVESTIGATOR
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Alabama
Birmingham, Alabama, United States
University of California-Long Beach
Long Beach, California, United States
University of California, Irvine Medical Center
Orange, California, United States
Christiana Care Health Services
Newark, Delaware, United States
Northwestern University
Chicago, Illinois, United States
National Institute of Child Health and Human Development (NICHD), 9000 Rockville
Bethesda, Maryland, United States
Columbia University
New York, New York, United States
Women and Infants
Providence, Rhode Island, United States
Medical University of S. Carolina
Charleston, South Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Grantz KL, Grewal J, Albert PS, Wapner R, D'Alton ME, Sciscione A, Grobman WA, Wing DA, Owen J, Newman RB, Chien EK, Gore-Langton RE, Kim S, Zhang C, Buck Louis GM, Hediger ML. Dichorionic twin trajectories: the NICHD Fetal Growth Studies. Am J Obstet Gynecol. 2016 Aug;215(2):221.e1-221.e16. doi: 10.1016/j.ajog.2016.04.044. Epub 2016 Apr 30.
Amyx MM, Albert PS, Bever AM, Hinkle SN, Owen J, Grobman WA, Newman RB, Chien EK, Gore-Langton RE, Buck Louis GM, Grantz KL. Intrauterine growth discordance across gestation and birthweight discordance in dichorionic twins. Am J Obstet Gynecol. 2020 Feb;222(2):174.e1-174.e10. doi: 10.1016/j.ajog.2019.08.027. Epub 2019 Aug 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11-CH-N178
Identifier Type: -
Identifier Source: secondary_id
999911178
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.